Myriad Genetics | 8-K: Myriad Genetics Reports Fourth Quarter Financial Results; Fourth Quarter Revenue of $177.8 Million Grew 11% Year-Over-Year Driven by 16% Growth in Hereditary Cancer Volumes and 23% Growth in GeneSight ® Volumes

萬基遺傳 | 8-K：Myriad Genetics公司公佈第四季度財務業績第四季度收入為1.778億美元，同比增長11%，這主要得益於遺傳性癌症業務增長16%和基因視覺®業務增長23%。